The use and impact of cancer medicines in routine clinical care: methods and observations in a cohort of elderly Australians
Open Access
Abstract
Introduction After medicines have been subsidised in Australia we know little about their use in routine clinical practice, impact on resource utilisation, effectiveness or safety. Routinely collected administrative health data are available to address these issues in large population-based pharmacoepidemiological studies. By bringing together cross-jurisdictional data collections that link drug exposure to real-world outcomes, this research programme aims to evaluate the use and impact of cancer medicines in a subset of elderly Australians in the real-world clinical setting. Methods and analysis This ongoing research programme involves a series of retrospective cohort studies of Australian Government Department of Veterans’ Affairs (DVA) clients. The study population includes 104 635 veterans who reside in New South Wales, Australia, and were aged 65 years and over as of 1 July 2004. We will investigate trends in cancer medicines use according to cancer type and other sociodemographic characteristics as well as predictors of the initiation of cancer medicines and other treatment modalities, survival and adverse outcomes among patients with cancer. The programme is underpinned by the linkage of eight health administrative databases under the custodianship of the DVA and the New South Wales Ministry of Health, including cancer notifications, medicines dispensing data, hospitalisation data and health services data. The cancer notifications database is available from 1994 with all other databases available from 2005 onwards. Ethics and dissemination Ethics approval has been granted by the DVA and New South Wales Population and Health Service Research Ethics Committees. Results Results will be reported in peer-reviewed publications, conference presentations and policy forums. The programme has high translational potential, providing invaluable evidence about cancer medicines in an elderly population who are under-represented in clinical trials.Keywords
This publication has 46 references indexed in Scilit:
- Discontinuation of statin therapy in older people: does a cancer diagnosis make a difference? An observational cohort study using data linkageBMJ Open, 2012
- Flexible modeling of the cumulative effects of time‐dependent exposures on the hazardStatistics in Medicine, 2009
- High-dimensional Propensity Score Adjustment in Studies of Treatment Effects Using Health Care Claims DataEpidemiology, 2009
- Uncovering the potential risk of serotonin toxicity in Australian veterans using pharmaceutical claims dataBritish Journal of Clinical Pharmacology, 2008
- Polypharmacy in elderly patientsThe American Journal of Geriatric Pharmacotherapy, 2007
- Potentially inappropriate prescribing among Australian veterans and war widows/widowersInternal Medicine Journal, 2007
- Treatment of 5-fluorouracil refractory metastatic colorectal cancer: an Australian population-based analysisBritish Journal of Cancer, 2007
- Adverse Drug Events Resulting from Patient Errors in Older AdultsJournal of the American Geriatrics Society, 2007
- Health services research using linked records: who consents and what is the gain?Australian and New Zealand Journal of Public Health, 2001
- A new method of classifying prognostic comorbidity in longitudinal studies: Development and validationJournal of Chronic Diseases, 1987